Epithelial transport of immunogenic and toxic gliadin peptides in vitro.

Celiac disease is an autoimmune disorder caused by failure of oral tolerance against gluten in genetically predisposed individuals. The epithelial translocation of gluten-derived gliadin peptides is an important pathogenetic step; the underlying mechanisms, however, are poorly understood. Thus, we i...

Full description

Bibliographic Details
Main Authors: Christian Zimmermann, Silvia Rudloff, Günter Lochnit, Sevgi Arampatzi, Wolfgang Maison, Klaus-Peter Zimmer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4240668?pdf=render
id doaj-d4a998fe0e3c497b8115933485c6df74
record_format Article
spelling doaj-d4a998fe0e3c497b8115933485c6df742020-11-25T01:20:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01911e11393210.1371/journal.pone.0113932Epithelial transport of immunogenic and toxic gliadin peptides in vitro.Christian ZimmermannSilvia RudloffGünter LochnitSevgi ArampatziWolfgang MaisonKlaus-Peter ZimmerCeliac disease is an autoimmune disorder caused by failure of oral tolerance against gluten in genetically predisposed individuals. The epithelial translocation of gluten-derived gliadin peptides is an important pathogenetic step; the underlying mechanisms, however, are poorly understood. Thus, we investigated the degradation and epithelial translocation of two different gliadin peptides, the toxic P31-43 and the immunogenic P56-68. As the size, and hence, the molecular weight of peptides might have an effect on the transport efficiency we chose two peptides of the same, rather short chain length.Fluorescence labeled P31-43 and P56-68 were synthesized and studied in a transwell system with human enterocytes. Fluorometric measurements were done to reveal antigen translocation and flow cytometry as well as confocal microscopy were used to investigate cellular uptake of peptides. Structural changes of these peptides were analysed by MALDI-TOF-MS. According to fluorescence intensities, significantly more P31-43 compared to P56-68 was transported through the enterocyte layer after 24 h incubation. In contrast to previous reports, however, mass spectrometric data do not only show a time-dependent cleavage of the immunogenic P56-68, but we observed for the first time the degradation of the toxic peptide P31-43 at the apical side of epithelial cells.Considering the degradation of gliadin peptides by enterocytes, measurement of fluorescence signals do not completely represent translocated intact gliadin peptides. From our experiments it is obvious that even short peptides can be digested prior to the translocation across the epithelial barrier. Thus, the chain length and the sensibility to degradations of gliadin peptides as well as the integrity of the epithelial barrier seem to be critical for the uptake of gliadin peptides and the subsequent inflammatory immune response.http://europepmc.org/articles/PMC4240668?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Christian Zimmermann
Silvia Rudloff
Günter Lochnit
Sevgi Arampatzi
Wolfgang Maison
Klaus-Peter Zimmer
spellingShingle Christian Zimmermann
Silvia Rudloff
Günter Lochnit
Sevgi Arampatzi
Wolfgang Maison
Klaus-Peter Zimmer
Epithelial transport of immunogenic and toxic gliadin peptides in vitro.
PLoS ONE
author_facet Christian Zimmermann
Silvia Rudloff
Günter Lochnit
Sevgi Arampatzi
Wolfgang Maison
Klaus-Peter Zimmer
author_sort Christian Zimmermann
title Epithelial transport of immunogenic and toxic gliadin peptides in vitro.
title_short Epithelial transport of immunogenic and toxic gliadin peptides in vitro.
title_full Epithelial transport of immunogenic and toxic gliadin peptides in vitro.
title_fullStr Epithelial transport of immunogenic and toxic gliadin peptides in vitro.
title_full_unstemmed Epithelial transport of immunogenic and toxic gliadin peptides in vitro.
title_sort epithelial transport of immunogenic and toxic gliadin peptides in vitro.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Celiac disease is an autoimmune disorder caused by failure of oral tolerance against gluten in genetically predisposed individuals. The epithelial translocation of gluten-derived gliadin peptides is an important pathogenetic step; the underlying mechanisms, however, are poorly understood. Thus, we investigated the degradation and epithelial translocation of two different gliadin peptides, the toxic P31-43 and the immunogenic P56-68. As the size, and hence, the molecular weight of peptides might have an effect on the transport efficiency we chose two peptides of the same, rather short chain length.Fluorescence labeled P31-43 and P56-68 were synthesized and studied in a transwell system with human enterocytes. Fluorometric measurements were done to reveal antigen translocation and flow cytometry as well as confocal microscopy were used to investigate cellular uptake of peptides. Structural changes of these peptides were analysed by MALDI-TOF-MS. According to fluorescence intensities, significantly more P31-43 compared to P56-68 was transported through the enterocyte layer after 24 h incubation. In contrast to previous reports, however, mass spectrometric data do not only show a time-dependent cleavage of the immunogenic P56-68, but we observed for the first time the degradation of the toxic peptide P31-43 at the apical side of epithelial cells.Considering the degradation of gliadin peptides by enterocytes, measurement of fluorescence signals do not completely represent translocated intact gliadin peptides. From our experiments it is obvious that even short peptides can be digested prior to the translocation across the epithelial barrier. Thus, the chain length and the sensibility to degradations of gliadin peptides as well as the integrity of the epithelial barrier seem to be critical for the uptake of gliadin peptides and the subsequent inflammatory immune response.
url http://europepmc.org/articles/PMC4240668?pdf=render
work_keys_str_mv AT christianzimmermann epithelialtransportofimmunogenicandtoxicgliadinpeptidesinvitro
AT silviarudloff epithelialtransportofimmunogenicandtoxicgliadinpeptidesinvitro
AT gunterlochnit epithelialtransportofimmunogenicandtoxicgliadinpeptidesinvitro
AT sevgiarampatzi epithelialtransportofimmunogenicandtoxicgliadinpeptidesinvitro
AT wolfgangmaison epithelialtransportofimmunogenicandtoxicgliadinpeptidesinvitro
AT klauspeterzimmer epithelialtransportofimmunogenicandtoxicgliadinpeptidesinvitro
_version_ 1725133172238188544